People

Mehdi Ainouche

jeito.life

Mehdi Ainouche is a Noema Pharma board member. Its published biography identifies him as a Jeito Capital partner with life-sciences investment experience across ophthalmology, oncology, CNS, cardiometabolic and neuromuscular conditions. His board membership does not by itself establish a personal investment in Noema. Mehdi joined Jeito Capital, a global leading independent Private Equity fund, with €534 million under management based in Paris and New York in 2020, following the launch of the fund, and was involved in several investments and portfolio companies notably in the fields of neurology, ophthalmology, oncology, cardiometabolic, neuromuscular diseases and fibrosis.  Prior to Jeito, Mehdi's last role was Associate within the healthcare venture team of Turenne Capital, a French investment group with over €1.8 billion under management, where he successfully participated to several investments in biotech & medtech. Mehdi holds a Pharmacy Doctorate from University of Rennes (France) and a Master in Business from ESCP Europe Business School Paris. Mehdi Ainouche is Jeito Capital’s current Partner. Joined 2020, became Partner 2025 following Principal and Senior Principal roles. Former Turenne healthcare investor; Rennes pharmacy doctorate and ESCP business masters.